EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1D
13 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
52 წუთის წინ
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
Traders Union
·
1 საათის წინ
Avalanche falls over 9% as seller pressure outweighs NYSE partnership boost
شبكة تواصل الإخبارية
·
31 წუთის წინ
Michael Burry doubled his bet against Nasdaq-100, warns of AI stock market correction
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc